TrialInternational journal of impotence research2013

Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs 50 years.

A D Seftel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.